Tag: Aubagio

Janssen’s Ponesimod OPTIMUM trial in MS meets primary endpoint

pharmanewsdaily- July 29, 2019

Ponesimod OPTIMUM trial results :  Johnson & Johnson's Janssen Pharmaceutical said that the phase 3 OPTIMUM clinical trial evaluating ponesimod yielded positive results compared to ... Read More